Skip to main content

Find Clinical Trials

Home
Conditions
Gaucher Disease

Clinical trial condition

Gaucher Disease

Explore clinical trials studying Gaucher Disease. Study availability and eligibility vary by location and protocol.

131 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Gaucher Disease trial results

Completed

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

NCT00813865

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations: Coral Springs, Florida, United States

Decatur, Georgia, United States

Boston, Massachusetts, United States

London, United Kingdom

View Trial Details

Completed

Stem Cell Transplant for Inborn Errors of Metabolism

NCT00176904

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +55 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

NCT02770625

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: Not specified

View Trial Details

Completed

Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease

NCT00244582

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease

NCT00465062

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Effects of Enzyme Replacement in Gaucher's Disease

NCT00001289

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease

NCT00041535

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

Institute of Child Health London, United Kingdom

View Trial Details

Completed

Exploration of Immunity in Gaucher Disease

NCT01358188

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations: Lysosomal Diseases Research and Treatment Center, CFCT Fairfax, Virginia, United States

View Trial Details

Completed

A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

NCT02536937

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Investigational Site Number 840004 Miami, Florida, United States

Investigational Site Number 840002 Saint Paul, Minnesota, United States

Investigational Site Number 840001 Knoxville, Tennessee, United States

View Trial Details

Completed

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)

NCT00891202

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: UCSF MS Center San Francisco, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

Emory University Medical Genetics Decatur, Georgia, United States

University of Kansas Medical Center, Division of Hematology/Oncology, Dept. of Medicine Westwood, Kansas, United States

View all 18 locations

View Trial Details